These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30101540)

  • 21. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
    Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
    Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
    Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
    Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Functional Nanogels as Theranostic Platforms: Exploiting Reversible and Nonreversible Linkages for Targeting, Imaging, and Drug Delivery.
    Chambre L; Degirmenci A; Sanyal R; Sanyal A
    Bioconjug Chem; 2018 Jun; 29(6):1885-1896. PubMed ID: 29727179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane heat shock protein 70: a theranostic target for cancer therapy.
    Shevtsov M; Huile G; Multhoff G
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1738):. PubMed ID: 29203711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A small molecule for theraNOstic targeting of cancer cells.
    Ravikumar G; Bagheri M; Saini DK; Chakrapani H
    Chem Commun (Camb); 2017 Dec; 53(100):13352-13355. PubMed ID: 29192700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
    Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
    Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes in cancer theranostic: Diamonds in the rough.
    Cordonnier M; Chanteloup G; Isambert N; Seigneuric R; Fumoleau P; Garrido C; Gobbo J
    Cell Adh Migr; 2017 Mar; 11(2):151-163. PubMed ID: 28166442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
    Kumar R; Shin WS; Sunwoo K; Kim WY; Koo S; Bhuniya S; Kim JS
    Chem Soc Rev; 2015 Oct; 44(19):6670-83. PubMed ID: 26118960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Care Using an Array of Radiolabelled Small Molecules.
    Mallia MB; Pillai MRA
    Bioessays; 2018 Oct; 40(10):e1800131. PubMed ID: 30137682
    [No Abstract]   [Full Text] [Related]  

  • 32. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
    Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
    Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
    Jiao Y; Sun Y; Tang X; Ren Q; Yang W
    Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small targeted cytotoxics from DNA-encoded chemical libraries.
    Samain F; Casi G
    Curr Opin Chem Biol; 2015 Jun; 26():72-9. PubMed ID: 25726911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small Molecule Fluorescent Probes for G- Quadruplex Visualization as Potential Cancer Theranostic Agents.
    Chilka P; Desai N; Datta B
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30791494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 39. Aggregation-Induced Emission (AIE) Dots: Emerging Theranostic Nanolights.
    Feng G; Liu B
    Acc Chem Res; 2018 Jun; 51(6):1404-1414. PubMed ID: 29733571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles.
    Tan J; Yang N; Zhong L; Tan J; Hu Z; Zhao Q; Gong W; Zhang Z; Zheng R; Lai Z; Li Y; Zhou C; Zhang G; Zheng D; Zhang Y; Wu S; Jiang X; Zhong J; Huang Y; Zhou S; Zhao Y
    Theranostics; 2017; 7(19):4862-4876. PubMed ID: 29187909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.